Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill Intensive Care Unit patients
- 1 October 2011
- journal article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 38 (4), 296-300
- https://doi.org/10.1016/j.ijantimicag.2011.05.007
Abstract
No abstract availableKeywords
Funding Information
- Research Funding, The First Affiliated Hospital of Medical College, Xi’an Jiaotong University (2008YK28)
This publication has 21 references indexed in Scilit:
- Treatment of Infections Caused By Antimicrobial-Resistant Gram-Positive BacteriaThe American Journal of the Medical Sciences, 2010
- Pharmacokinetics of linezolid in septic patients with and without extended dialysisEuropean Journal of Clinical Pharmacology, 2009
- Role of Old Antibiotics in Multidrug Resistant Bacterial InfectionsCurrent Drug Targets, 2009
- Pharmacokinetic evaluation of linezolid in patients with major thermal injuriesJournal of Antimicrobial Chemotherapy, 2009
- How to break the vicious circle of antibiotic resistances?Current Opinion in Critical Care, 2008
- An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unitJournal of Antimicrobial Chemotherapy, 2008
- Pharmacodynamic Activity and Efficacy of Linezolid in a Rat Model of Pneumococcal PneumoniaAntimicrobial Agents and Chemotherapy, 2002
- Linezolid for the Treatment of Resistant Gram-Positive CocciAnnals of Pharmacotherapy, 2001
- Successful Treatment of Persistent Vancomycin‐Resistant Enterococcus faecium Bacteremia with Linezolid and GentamicinClinical Infectious Diseases, 1999
- Oxazolidinones, a new class of synthetic antituberculosis agent in vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosisDiagnostic Microbiology and Infectious Disease, 1991